Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Perflubutane-enhanced endoscopic ultrasonography in suspected pancreatobiliary tumors (PEUS study)
jRCTs071180072Recruiting
- Start
- Jan 2014
- Modality
- Acoustic/Optical: Sonoporation, laser photoporation → Physical Methods → Gene Addition/Replacement → Gene Therapies, Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Open-label, single-arm trial of sonazoid in pancreatic cancer (PC), biliary cancer and pancreaticobiliary diseases. Primary endpoint: Differential diagnosis of suspected biliary and pancreatic tumors. Started Jan 2014; status: recruiting.
02
Drugs
sonazoid
03
Conditions
pancreatic cancer (PC)biliary cancerpancreaticobiliary diseases
Beyond the preview
Go deeper on jRCTs071180072.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs071180072.